Dermatology · Bronx, NY
NPI
1598861510
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1650 Selwyn Ave
Bronx, NY, 10457
Phone (718) 960-1234
Groups this clinician bills Medicare through
Medicare paid, 2024
$63K
981 services
Medicare patients, 2024
328
Average age 73
Drug cost, 2024
$1.3M
4,562 prescriptions
Company payments, 2025
$701
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pamela J Jakubowicz was code 99213 (office e&m - established), 174 times for 138 patients. In total Pamela J Jakubowicz billed 981 services in 19 codes, and Medicare paid $63K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 174 | 138 | $82.76 | $14K |
| 99214 Office E&M - Established | Office | 160 | 130 | $101.58 | $16K |
| 17000 Destruction Skin Lesion | Office | 132 | 95 | $59.44 | $7,847 |
| 17003 Destruction Skin Lesion | Office | 91 | 63 | $5.89 | $536 |
| 99212 Office E&M - Established | Office | 86 | 79 | $52.30 | $4,498 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 66 | 58 | $15.27 | $1,008 |
| 99203 Office E&M - New | Office | 58 | 58 | $93.36 | $5,415 |
| 11900 Skin | Office | 56 | 20 | $53.61 | $3,002 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 51 | 18 | $0.76 | $38.8 |
| 99204 Office E&M - New | Office | 34 | 34 | $134.39 | $4,569 |
| 11102 Skin Biopsy | Office | 33 | 32 | $88.05 | $2,906 |
| 99202 Office E&M - New | Office | 21 | 21 | $61.79 | $1,298 |
By year: 2022 $56K for 899 services; 2023 $53K for 756 services; 2024 $63K for 981 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pamela J Jakubowicz prescribed most often to Medicare patients was Betamethasone Dipropionate, with 490 prescriptions and refills. In total Pamela J Jakubowicz wrote 4,562 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Betamethasone Dipropionate Generic | 490 | 501 | 163 | $18K |
| Ketoconazole Generic | 346 | 361 | 107 | $8,288 |
| Ammonium Lactate Generic | 281 | 298 | 89 | $6,991 |
| Imiquimod Generic | 280 | 355 | 142 | $17K |
| Tacrolimus Generic | 267 | 295 | 91 | $61K |
| Triamcinolone Acetonide Generic | 231 | 268 | 87 | $4,300 |
| Nystatin Generic | 191 | 198 | 75 | $4,878 |
| Selenium Sulfide Generic | 155 | 158 | 55 | $1,446 |
| Nyamyc Nystatin | 122 | 124 | 49 | $3,547 |
| Ciclopirox Generic | 121 | 140 | 58 | $10K |
| Metronidazole Generic | 117 | 126 | 48 | $6,356 |
| Fluocinolone Acetonide Generic | 105 | 106 | 38 | $4,517 |
| Hydrocortisone Generic | 102 | 112 | 28 | $2,615 |
| Klayesta Nystatin | 98 | 98 | 45 | $2,356 |
| Clobetasol Propionate Generic | 93 | 99 | 29 | $3,114 |
Brand drugs: 552 claims; generic drugs: 4,010 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pamela J Jakubowicz $701 ($701 in general payments such as food, travel and fees) from 9 companies. The largest payer was Botanix SB Inc with $149.
| Company | Payments | Amount |
|---|---|---|
| Botanix SB Inc | 2 | $149 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $125 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $125 |
| Incyte Corporation INCY | 4 | $109 |
| Genzyme Corporation SNY | 2 | $62.12 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $52.19 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $27.27 |
| Amgen Inc. AMGN | 1 | $25.91 |
| Lilly USA, LLC LLY | 1 | $24.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.